These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8051393)

  • 1. Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities. C.A.L.C. Group. Coagulation Abnormalities in Cirrhosis Study Group.
    Violi F; Leo R; Vezza E; Basili S; Cordova C; Balsano F
    J Hepatol; 1994 Apr; 20(4):531-6. PubMed ID: 8051393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding time in patients with hepatic cirrhosis.
    Blake JC; Sprengers D; Grech P; McCormick PA; McIntyre N; Burroughs AK
    BMJ; 1990 Jul; 301(6742):12-5. PubMed ID: 2383699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study.
    Violi F; Leo R; Basili S; Ferro D; Cordova C; Balsano F;
    Haematologica; 1994; 79(1):61-5. PubMed ID: 15378950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
    Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
    Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of hemostatic profile in patients with mild to advanced liver cirrhosis.
    Adam EH; Möhlmann M; Herrmann E; Schneider S; Zacharowski K; Zeuzem S; Weber CF; Weiler N
    World J Gastroenterol; 2020 May; 26(17):2097-2110. PubMed ID: 32536777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation parameters and major bleeding in critically ill patients with cirrhosis.
    Drolz A; Horvatits T; Roedl K; Rutter K; Staufer K; Kneidinger N; Holzinger U; Zauner C; Schellongowski P; Heinz G; Perkmann T; Kluge S; Trauner M; Fuhrmann V
    Hepatology; 2016 Aug; 64(2):556-68. PubMed ID: 27124745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGA Clinical Practice Update: Coagulation in Cirrhosis.
    O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
    Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
    Violi F; Basili S; Raparelli V; Chowdary P; Gatt A; Burroughs AK
    J Hepatol; 2011 Dec; 55(6):1415-27. PubMed ID: 21718668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver cirrhosis--procoagulant stasis].
    Prelipcean CC; Fierbinteanu-Braticevici C; Drug VL; Lăcătuşu C; Mihai B; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):678-85. PubMed ID: 22046771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
    Basili S; Ferro D; Leo R; Juliano L; Alessandri C; Cordova C; Violi F
    J Hepatol; 1996 May; 24(5):574-80. PubMed ID: 8773913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of disorders of primary hemostasis in the occurrence of upper digestive hemorrhage in cirrhosis].
    Audhuy B; Doffoel M; Wiesel ML; Hemmendinger S; Cazenave JP; Bockel R
    Ann Gastroenterol Hepatol (Paris); 1984; 20(4):177-82. PubMed ID: 6335645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features.
    Zanetto A; Rinder HM; Campello E; Saggiorato G; Deng Y; Ciarleglio M; Wilson FP; Senzolo M; Gavasso S; Bulato C; Simioni P; Garcia-Tsao G
    Hepatology; 2020 Oct; 72(4):1327-1340. PubMed ID: 32614088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic changes in patients with liver cirrhosis.
    Ho CH; Hou MC; Lin HC; Lee FY; Wu JC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):376-82. PubMed ID: 10389296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver diseases and hemostasis].
    Denninger MH
    Pathol Biol (Paris); 1999 Nov; 47(9):1006-15. PubMed ID: 10609281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation abnormalities in patients with chronic liver disease in Pakistan.
    Siddiqui SA; Ahmed M; Ghani MH; Memon MA; Mustafa G; Ghori MA
    J Pak Med Assoc; 2011 Apr; 61(4):363-7. PubMed ID: 21465974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coagulation system in patients with end-stage liver disease.
    Valla DC; Rautou PE
    Liver Int; 2015 Jan; 35 Suppl 1():139-44. PubMed ID: 25529099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    Stein SF; Harker LA
    J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K time & maximum amplitude of thromboelastogram predict post-central venous cannulation bleeding in patients with cirrhosis: A pilot study.
    Pandey CK; Saluja V; Gaurav K; Tandon M; Pandey VK; Bhadoria AS
    Indian J Med Res; 2017 Jan; 145(1):84-89. PubMed ID: 28574019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The primary haemostasis is more preserved in thrombocytopenic patients with liver cirrhosis than cancer.
    Vinholt PJ; Alnor AB; Nybo M; Hvas AM
    Blood Coagul Fibrinolysis; 2018 Apr; 29(3):307-313. PubMed ID: 29561276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk factors and systemic endothelial function in patients with cirrhosis.
    Berzigotti A; Erice E; Gilabert R; Reverter E; Abraldes JG; García-Pagan JC; Bosch J
    Am J Gastroenterol; 2013 Jan; 108(1):75-82. PubMed ID: 23147518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.